Ampersand Adds Operating Partner

Ampersand Adds Operating Partner

Ampersand Capital Partners has added Cecil Kost to its team as an Operating Partner. Mr. Kost will be involved in identifying and evaluating new platform investments as well as assisting on the existing portfolio investments of Ampersand.

Mr. Kost has more than 30 years of healthcare operating experience in Ampersand’s target investment segments including laboratory/diagnostics products, pharmaceutical services and medical products. Most recently he served as President and CEO of Precision Dynamics, a manufacturer of patient identification products. Prior experience includes serving as CEO of MedManage Systems and President/COO of Oncor. He began his career at Curtin Matheson Scientific, a distributor of lab products and clinical diagnostics, where he spent nearly 20 years serving in senior management roles prior to its acquisition by Fisher Scientific. Mr. Kost has a BS degree from Tulane University.

“I am thrilled to join the Ampersand team,” said Mr. Kost. “I believe that Ampersand is well positioned to partner with growth-oriented middle market companies, and I am looking forward to working with the Ampersand team to create meaningful value in their portfolio companies.”

Ampersand Capital Partners makes middle market growth equity investments in the healthcare sector. Over the past twenty years, Ampersand has raised seven funds and invested in more than forty private healthcare companies. These activities have produced a 24% net pooled internal rate of return to the firm’s limited partners. Ampersand is based in Wellesley, MA (

“We are excited to have Cecil join Ampersand,” said Herbert Hooper, Managing Partner at Ampersand. “Cecil’s experience in our core investment segments is highly complementary to our team. I am confident that Cecil will be able to leverage his years of operational experience to identify quality healthcare businesses that can benefit from Ampersand’s unique expertise, and then help them achieve their goals.”

© 2013 PEPD • Private Equity’s Leading News Magazine • 6-12-13

To search in site, type your keyword and hit enter